Hsin Yuan Chen | Engineering | Best Scholar Award

Prof. Hsin Yuan Chen | Engineering | Best Scholar Award

Professor at Zhejiang University | China

Dr. Hsin Yuan Chen is a leading scholar and technologist, currently serving as a Changjiang Scholar Professor and Director at Zhejiang University’s Institute of Wenzhou, Center of Digital Technology Entrepreneurship and Innovation. With an extensive academic and industrial background, she has made significant contributions in smart agriculture, AI, robotics, and digital transformation. Dr. Chen’s interdisciplinary expertise bridges engineering, healthcare, and artificial intelligence, and her work has impacted education, industry collaboration, and technological advancement across Asia. Her recognition includes international fellowships, keynote speaker roles, and leadership in major research centers, positioning her as a dynamic force in intelligent systems and innovation.

Profile:

Google Scholar

Education:

Dr. Hsin Yuan Chen earned her Bachelor’s and Ph.D. degrees in Aerospace Engineering from National Cheng Kung University, Taiwan, completing her doctorate in 2000. She complemented her formal education with a visiting professorship at Washington University in St. Louis, USA, which deepened her global academic perspective. Her educational journey has been distinguished by a strong foundation in systems control, aerospace, and robotics, which later evolved to encompass AI, digital agriculture, and interdisciplinary technology management. This robust academic training underpins her approach to integrating theoretical insights with practical innovations in smart technologies and data-driven platforms.

Experience:

Dr. Hsin Yuan Chen’s professional journey spans over two decades of academic, governmental, and industrial roles. She served as Professor and Dean at Fujian Normal University, CTO at GEOSAT Technology and Mobiletron Electronics, and Assistant Professor at multiple Taiwanese institutions. Additionally, she held advisory roles in patent offices and high-tech companies, contributing to projects on AI positioning systems, smart agriculture, and unmanned vehicles. Her international engagements include collaborations with institutions such as McGill University and Washington University. These diverse experiences enrich her ability to lead transdisciplinary teams and execute complex, innovation-focused initiatives across multiple sectors.

Research Interest:

Dr. Hsin Yuan Chen’s research focuses on the convergence of artificial intelligence, smart agriculture, IoT, blockchain, and autonomous systems. Her projects have addressed real-world challenges in digital transformation, healthcare innovation, and sustainable agriculture. A particular interest lies in integrating explainable AI with blockchain to enhance decision-making in agricultural technology. She is also actively involved in robotics, wireless positioning systems, and medical platforms leveraging sensor technology. Her passion for developing inclusive, intelligent systems is reflected in her projects like AI Doctors for crops and Paro Robots for health monitoring, aiming to merge emotion detection with deep learning-based automation.

Awards and Honors:

Dr. Hsin Yuan Chen has received prestigious accolades including the ScienceFather International Outstanding Scientist Award (2024), IET Fellowship (2023), and ASEAN Fellowship (2022). She was recognized with national teaching excellence awards, innovation medals in higher education, and championship titles in robotics competitions. Her pioneering work has also earned distinctions in cloud technology and virtual cultural heritage. As a member of high-level talent programs in Zhejiang and Fujian Provinces, and a recipient of multiple creativity group medals, Dr. Chen’s impact extends across education, technology, and international science forums. Her awards reflect both scholarly excellence and societal contributions.

Publications:

Title: Exploring the sensitivity of next generation gravitational wave detectors

Citations: 1533

Year of Publication: 2017

Title: Cosmology intertwined: A review of the particle physics, astrophysics, and cosmology associated with the cosmological tensions and anomalies

Citations: 1322

Year of Publication: 2022

Title: Carbon nanotube computer

Citations: 1228

Year of Publication: 2013

Title: Three dimensional reconstruction of a solid-oxide fuel-cell anode

Citations: 1019

Year of Publication: 2006

Title: GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

Citations: 895

Year of Publication: 2008

Title: Plasmonic nanolaser using epitaxially grown silver film

Citations: 878

Year of Publication: 2012

Title: Translation and back‐translation in qualitative nursing research: methodological review

Citations: 874

Year of Publication: 2010

Title: Mapping the Evolution: A Bibliometric Analysis of Employee Engagement and Performance in the Age of AI-Based Solutions
Year of Publication: 2025

Title: Advancements in Handwritten Devanagari Character Recognition: A Study on Transfer Learning and VGG16 Algorithm
Citations: 3
Year of Publication: 2024

Title: Intellectual Structure of Explainable Artificial Intelligence: A Bibliometric Reference to Research Constituents
Year of Publication: 2024

Title: Integrating Explainable Artificial Intelligence and Blockchain to Smart Agriculture: Research Prospects for Decision Making and Improved Security
Citations: 39
Year of Publication: 2023

Conclusion:

Dr. Hsin Yuan Chen exemplifies excellence in research, leadership, and innovation, making her a strong candidate for the Best Researcher Award. Her prolific output in scientific publications, transformative projects in smart agriculture and digital health, and her commitment to knowledge transfer through academia-industry collaborations illustrate her deep impact. Dr. Chen’s fusion of AI with real-world applications—particularly in sustainable systems and intelligent automation—positions her at the forefront of global innovation. Her recognition across international platforms affirms her thought leadership and the lasting value of her contributions to science, technology, and education.

Jorge Zumaeta | Economics | Best Researcher Award

Dr. Jorge Zumaeta | Economics | Best Researcher Award 

Professor at Florida International University | United States 

Dr. Jorge Zumaeta is a distinguished scholar and senior academic administrator whose career spans over three decades in macroeconomics, labor economics, and socio-economic development. He serves as Senior Director at Florida International University and a Senior Research Affiliate at Duke University’s Samuel DuBois Cook Center on Social Equity. His work bridges academic research with community-focused economic policy, emphasizing equity, liberty, and workforce development. Known for his exceptional leadership, he has contributed to national policy through high-impact research, strategic planning, and cross-institutional collaborations. Dr. Jorge Zumaeta is committed to preparing future leaders with an ethical and economically informed worldview grounded in classical and modern principles.

Profile:

Orcid | Google Scholar

Education:

Dr. Jorge Zumaeta holds a Ph.D. in Social Science from Tilburg University in the Netherlands, an M.S. in Economics from Florida Atlantic University, and a B.A. in Economics from the same institution. His academic training combines rigorous theoretical foundations with applied economic methodologies, particularly in labor markets and macroeconomic stability. His doctoral work emphasized the intersection of economic equity and academic access. Throughout his academic path, Dr. Jorge Zumaeta has remained focused on empowering underrepresented communities through education and economic opportunity. His transatlantic education has shaped his global perspective and guided his commitment to equitable development through evidence-based research.

Experience:

With a career rooted in both public and academic sectors, Dr. Jorge Zumaeta has held leadership roles at Florida International University since 2007, managing academic planning, accreditation, and workforce alignment initiatives. He previously worked with Miami-Dade County as a Senior Economic and Policy Analyst, and earlier served as Associate Director at Florida Atlantic University’s employment training institute. His experience spans strategic policy development, econometric research, community redevelopment planning, and fiscal management. He has led national and international presentations, developed economic indicators, and collaborated with federal agencies. His practical insights have directly influenced labor policy, workforce strategies, and institutional effectiveness across various regions.

Research Interest:

Dr. Jorge Zumaeta’s research lies at the nexus of applied macroeconomics, labor market dynamics, and socio-economic equity. His recent studies explore disparities in income, wealth, and incarceration, particularly in minority communities. He utilizes advanced econometric tools to evaluate the impact of job training programs, academic policy interventions, and misinformation in the digital age. A significant portion of his work assesses the socioeconomic effects of institutional structures, aiming to offer policy solutions rooted in academic rigor and equity frameworks. His interdisciplinary focus blends economics, public policy and data science to produce insights that serve both scholarship and real-world transformation.

Awards and Honors:

Dr. Jorge Zumaeta’s contributions have earned him numerous accolades, including the Fulbright Research Chair, FIU FLAME Award, APEX Award , and High Impact Leadership Award. He was a Top Scholar at FIU and received multiple community engagement recognitions, such as nominations for the SPOT and Community Awards. As a National Science Foundation DITE Fellow and Faculty Mentor, he has mentored emerging economists in diversity-driven research. His strategic involvement with county-level economic councils and chambers reflects his leadership in policy-making and commitment to advancing equitable development through multidisciplinary collaboration.

Publications Top Notes:

Title: Racial Disparities in Family Income, Assets, and Liabilities: A Century After the 1921 Tulsa Massacre
Citations: 3
Year of Publications: 2024

Title: The Incarceration Penalty and Black-White Economic Inequality: The Case of Baltimore
Citations: 1
Years of Publications: 2023

Title: Money Illusion in Charitable Giving in the Absence of Market Price Resistance
Citations: 1
Year of Publications: 2021

Title: A Logistic Regression Analysis to Assist Welfare Recipients Attaining Employment
Citations: 1
Year of Publications: 2021

Title: Meta-Analysis of Seven Standard Experimental Paradigms Comparing Student to Non-student
Citations: 1
Year of Publications: 2021

Conclusion:

Dr. Jorge Zumaeta exemplifies the values of a visionary researcher and public intellectual. His integration of academic inquiry with policy application positions him as a transformative leader in economics and public service. His contributions span publications, federal research initiatives, curriculum development, and community advocacy, making him a deserving nominee for the Best Researcher Award. His scholarly impact and unwavering dedication to social equity, economic development, and educational access embody the spirit of excellence and civic responsibility. Recognizing Dr. Zumaeta would honor a career dedicated to uplifting communities through evidence-based research and inclusive education.

Maria Rosa Gigliobianco | Nanotechnology and cosmetics research | Best Researcher Award

Prof. Maria Rosa Gigliobianco | Nanotechnology and cosmetics research | Best Researcher Award

Reseacher at University G. D’Annunzio of Chieti and Pescara | Italy

Dr.Maria Rosa Gigliobianco is a pharmaceutical scientist and researcher specializing in nanomedicine and drug delivery systems. Currently serving as a researcher (RTD-A) at the University of G. d’Annunzio, she is the Principal Investigator of a government-funded project on nanonetwork strategies for cancer treatment. Her work bridges pharmaceutical chemistry and biomedical innovation, focusing on novel biomaterials, hydrogels, and nanoparticle-based systems. With experience across European institutions and participation in prestigious fellowships like the Marie Skłodowska-Curie, Dr. Gigliobianco has become a recognized expert in drug delivery and formulation. Her dynamic career has impacted biomedical research and the development of targeted therapeutic systems.

Profile:

Orcid  | Google Scholar 

Education:

Dr.Maria Rosa Gigliobianco earned dual Master’s degrees in Pharmacy and Pharmaceutical Chemistry and Technology from the University of Camerino, where she also completed a Ph.D. in Chemical and Pharmaceutical Sciences and Biotechnologies. Her doctoral research involved synthesizing and characterizing targeted polymeric nanoparticles for biomedical applications, integrating techniques such as DLS, NMR, HPLC, FTIR, SEM, and in vitro studies. She holds a pharmacist license and has built a solid foundation in formulation science and nanoparticle engineering. Her academic training has provided her with a multidisciplinary edge that complements her postdoctoral research in cosmetic, pharmaceutical, and biomaterial-based drug delivery innovations.

Professional Experience:

Dr.Maria Rosa Gigliobianco’s professional journey spans academia and international research centers. She has held multiple postdoctoral positions at the University of Camerino and served as a senior scientist at Percuros BV in the Netherlands under the MSCA Individual Fellowship. Her career includes significant contributions to cancer nanotherapy, nose-to-brain delivery systems, and the formulation of natural biomaterials. Currently, she leads a nanonetwork cancer therapy project as PI. Dr. Gigliobianco has also been a visiting researcher at LUMC in Leiden and lectures as a subject expert in pharmaceutical technology. Her mentorship of over 30 master’s students and 10 Ph.D. researchers demonstrates her academic leadership.

Research Interests:

Her research centers on the design and development of innovative nano- and macro-delivery platforms for pharmaceutical and cosmetic applications. She focuses on polymeric nanoparticles, hydrogels, bioactive compounds, and nanocrystals aimed at overcoming bioavailability challenges, particularly in cancer and neurodegenerative conditions. Dr. Gigliobianco is deeply invested in using waste-derived biomaterials for sustainable formulations. She applies advanced analytical techniques for material characterization and emphasizes nose-to-brain delivery strategies. Her work contributes to the evolution of eco-friendly, patient-centric therapies and fosters interdisciplinary collaborations in biomaterials, biotechnology, and therapeutic formulation.

Awards and Honors:

Dr.Maria Rosa Gigliobianco has received several prestigious accolades. she was awarded the MSCA Individual European Fellowship, a competitive grant for innovative European research. She earned “Best Poster Presentation” awards, including from the CRS Italy Chapter. Her master’s thesis was honored with the “Donna e Scienza” Rita Levi Montalcini award. She also received competitive fellowships from the University of Camerino during her Master’s and Ph.D. studies. These recognitions reflect her scientific excellence and commitment to advancing pharmaceutical technology through innovative research and public dissemination of knowledge.

Publications:

Title: Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability
Citations: 305
Published Year: 2018

Title: Hot Melt Extrusion: Highlighting Physicochemical Factors to Be Investigated While Designing and Optimizing a Hot Melt Extrusion Process
Citations: 152
Published Year: 2018

Title: Nano-medicine improving the bioavailability of small molecules for the prevention of neurodegenerative diseases
Citations: 32
Published Year: 2017

Title: New nanometric solid dispersions of glibenclamide in Neusilin® UFL2
Citations: 19
Published Year: 2016

Title: Formation, physicochemical characterization, and thermodynamic stability of the amorphous state of drugs and excipients
Citations: 12
Published Year: 2016

Title: Effect of poly (vinylpyrrolidone) or sodium alginate on the stability of the amorphous form of nimesulide
Citations: 8
Published Year: 2016

Title: Effect of Grinding on the Solid-State Stability and Particle Dissolution of Acyclovir Polymorphs
Citations: 7
Published Year: 2017

Conclusion:

Dr.Maria Rosa Gigliobianco is a highly qualified nominee for a research award recognizing excellence in nanomedicine and pharmaceutical sciences. Her multidisciplinary expertise, sustained research productivity, and commitment to training future scientists make her a valuable contributor to scientific advancement. Her projects address urgent healthcare challenges with innovative, sustainable, and practical solutions. Recognized by European institutions and academia, she continues to lead impactful research in cancer therapy, neurodegenerative diseases, and eco-friendly formulation technologies. Her achievements exemplify the caliber and vision required for global scientific recognition in medicine and biopharmaceutical innovation.

Amanda Lee | Nursing and Health Professions | Best Researcher Award

Dr Amanda Lee | Nursing and Health Professions | Best Researcher Award

Snr Lecturer at Manchester Metropolitan University, United Kingdom.

Dr. Amanda Lee is a globally recognized academic leader, nurse practitioner, and health sciences researcher whose career spans over three decades and four continents. With qualifications in adult nursing, midwifery, and advanced clinical practice, she has made outstanding contributions to clinical care, higher education, health policy, and interdisciplinary research. Holding a PhD in Health Sciences with a specialization in cancer epidemiology, Dr. Lee has developed pioneering methodologies that integrate health and geospatial sciences to improve healthcare planning. She is known not only for her scholarly output but also for her leadership in shaping transnational education programs and advising governmental healthcare bodies in the UK, Australia, Singapore, and China.

Profile:

Education:

Dr. Lee’s academic journey reflects a profound commitment to lifelong learning. She holds a PhD in Health Sciences from the University of Hull, an MSc in Nurse Practitioner studies from Curtin University in Australia, a BSc Hons in Midwifery from Leeds University, and several postgraduate diplomas in education and advanced nursing practice. Her broad academic foundation across nursing, midwifery, education, and research methodology has empowered her to lead in both clinical and academic environments with confidence and authority.

💼 Professional Experience:

Dr. Amanda Lee is a seasoned healthcare academic and leader with over 30 years of diverse professional experience spanning clinical practice, higher education, research, and international consultancy. She has held senior roles such as Executive Dean, Associate Dean (International), and Senior Lecturer across institutions in the UK, Australia, and Asia. Her career highlights include leading transnational nursing programs, supervising PhD students, securing competitive research funding, and advising government health bodies on advanced practice, non-medical prescribing, and educational strategy. Clinically, she has served as a neonatal nurse, ward sister, and nurse practitioner, and academically, she has managed multidisciplinary teams and developed inclusive, evidence-informed curricula for global healthcare education.

🧪 Research Excellence:

With over 41 peer-reviewed publications, an h-index of 12, and more than 740 citations, Dr. Lee is a prolific contributor to the global body of knowledge in health sciences. Her research interests include cancer epidemiology, nursing education, health geographics, and community-based interventions. Notably, her PhD work developed an innovative population health model using geographical data to anticipate healthcare needs—a methodology with broad interdisciplinary relevance. She has successfully secured major grants, serving as both Principal Investigator and Co-Investigator on nationally and internationally funded research projects.

🌍 Global Impact & Leadership:

Dr. Lee’s influence transcends borders. She has led international collaborations in China, Saudi Arabia, and India, and has designed and implemented transnational nursing degree programs. She is a Visiting Professor at Yangzhou University in China and has advised national healthcare bodies including the UK’s MHRA and Australia’s Nursing and Midwifery Council. Her role as Executive Dean at the Global Banking School involved leading 300+ staff across 10+ campuses and overseeing educational strategies for over 10,000 students. She was instrumental in developing nurse-led clinics in Australia and advising on non-medical prescribing initiatives in Singapore.

🏅 Awards & Recognition:

Dr. Lee has held prestigious appointments, such as serving on editorial boards of top journals including Nurse Education in Practice, BMJ Open, and Journal of Clinical Nursing. She is a Senior Fellow of the Higher Education Academy (SFHEA) and an accredited researcher with the UK Office for National Statistics. In 2024, she was honored as an international judge for the Saudi Government’s health research awards, recognizing her global expertise in patient safety and critical care.

Publications:

  • Cognitive impairment and dementia – Are they linked to childhood health and socioeconomic status? A systematic review

  • ‘Hearing silences’: Exploring culturally safe transitional care: A qualitative study among Turkish-speaking migrant frail older adults

  • Effectiveness of spontaneous pushing versus Valsalva pushing in the second stage of labor on maternal and neonatal outcomes: A systematic review and meta-analysis

  • Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: A qualitative study

  • Diverse Molecular Structures Across The Whole Star-Forming Disk of M83: High fidelity Imaging at 40pc Resolution

  • Severe Loneliness and Isolation in Nursing Students during COVID-19 Lockdown: A Phenomenological Study

  • Trajectory analysis of the work and life experience of healthcare workers during the COVID-19 pandemic: A longitudinal qualitative study

  • Predictors of long-term survival in 5,680 patients admitted to a UK major trauma centre with thoracic injuries

  • Experiences of domestic violence prevention interventions and gender equality promotion work: A qualitative study of Nirdhar Groups in rural India

  • Anxiety and sleep quality among front-line nurses treating first wave COVID-19 in China: The mediating role of mindfulness

Mr.Mulat Erkihun | Immunology and Microbiology | Best Scholar Award

Mr.  Mulat Erkihun | Immunology and Microbiology | Best Scholar Award

lecturer at Debre Tabor University, Ethiopia.

Mulat Erkihun Agaje is a distinguished Ethiopian medical microbiologist, educator, and clinical researcher with a strong commitment to combating infectious diseases and antimicrobial resistance. With a dual role as a lecturer at Debre Tabor University and a clinical microbiologist at Debre Tabor Comprehensive Specialized Hospital, he bridges academic research with real-world healthcare solutions. His career reflects a passion for medical science, community impact, and advancing diagnostic microbiology.

Profile:

🎓 Education:

Mulat holds a Master of Science in Medical Microbiology (2019) from Bahir Dar University, where he graduated with Very Great Distinction. His M.Sc. coursework focused on advanced virology, bacteriology, immunology, microbial genetics, and hospital infection control. His thesis investigated the antimicrobial resistance profile of Helicobacter pylori in patients with gastric diseases. He also earned a Bachelor of Science in Medical Laboratory Science (2016) from Haramaya University, again graduating with Very Great Distinction. Both programs were conducted in English and included research components.

Professional Experience:

With over eight years of clinical and academic experience, Mulat began his journey as a medical laboratory technologist and then a clinical microbiologist at Felege Hiwot Comprehensive Specialized Hospital. Since 2022, he has served as a lecturer and researcher at Debre Tabor University, where he teaches medical students, supervises research, develops curricula, and provides microbiological services in the affiliated hospital. He has also led quality assurance, community outreach, and strategic laboratory improvements using Lean and Six Sigma approaches.

Research Interests:

Mulat’s research spans a broad spectrum of medical microbiology. His core interests include pathogenesis of infectious diseases, molecular diagnostics, antimicrobial resistance mechanisms, microbial genetics, and the use of nanomaterials in medical applications. He also explores biofilm formation, quorum sensing, vaccine development, and molecular etiology of diseases using PCR and microarray technologies. His multidisciplinary focus contributes to both fundamental science and clinical application.

Awards & Recognition:

Mulat is a recipient of multiple Best Researcher Awards from reputable international platforms in the fields of nanobiotechnology, immunology, and medical microbiology. These awards recognize his outstanding contribution to science, impactful publications, and innovative research on infectious disease management and antimicrobial resistance.

Editorial Activities:

Mulat is an active peer reviewer for leading journals including PLoS ONE, Scientific Reports, and Heliyon. His expertise is sought for evaluating manuscripts on infectious diseases, tuberculosis, and bacterial pathogenesis. His reviewing role showcases his standing in the global microbiological research community.

Professional Memberships:

He is a proud member of the American Society for Microbiology (ASM), Ethiopian Medical Laboratory Association, Health Professionals Association, and Ethiopian Teachers Association. These affiliations support his commitment to continuous learning and global collaboration.

Publications:

  • Erkihun, M., Asmare, Z., Endalamaw, K., Getie, B., Kiros, T., & Berhan, A. (2024). Medical scope of biofilm and quorum sensing during biofilm formation: Systematic review. Bacteria, 3(3), 118–135.
    [Cited by: 19]

  • Asmare, Z., & Erkihun, M. (2023). Recent application of DNA microarray techniques to diagnose infectious disease. Pathology and Laboratory Medicine International, 77–82.
    [Cited by: 10]

  • Erkihun, M., Ayele, B., Asmare, Z., & Endalamaw, K. (2024). Current Updates on Variants of SARS‐CoV‐2: Systematic Review. Health Science Reports, 7(11), e70166.
    [Cited by: 9]

  • Asmare, Z., Erkihun, M., Abebe, W., Ashagre, A., Misganaw, T., & Feleke, S. F. (2024). Catheter-associated urinary tract infections in Africa: Systematic review and meta-analysis. Infection, Disease & Health, 29(3), 172–179.
    [Cited by: 9]

  • Berhan, A., Almaw, A., Solomon, Y., Legese, B., Damtie, S., Erkihun, M., et al. (2023). Tuberculosis treatment outcome and associated factors among tuberculosis patients linked to tuberculosis treatment clinics in Ethiopia, 2023: A multi-center retrospective study. Infection and Drug Resistance, 3367–3378.
    [Cited by: 9]

  • Asmare, Z., Erkihun, M., Abebe, W., & Tamrat, E. (2024). Antimicrobial resistance and ESBL production in uropathogenic Escherichia coli: A systematic review and meta-analysis in Ethiopia. JAC-Antimicrobial Resistance, 6(3), dlae068.
    [Cited by: 5]

  • Kiros, T., Erkihun, M., Wondmagegn, M., Almaw, A., Assefa, A., Berhan, A., et al. (2025). Assessment of Knowledge, Attitude, and Associated Factors of Mpox Among Healthcare Professionals at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia, 2024: A cross-sectional study. Health Science Reports, 8(1), e70371.
    [Cited by: 3]

  • Berhan, A., Damtie, S., Almaw, A., Legese, B., Sharew, B., Getie, B., Erkihun, M., et al. (2024). The role of extracorporeal photopheresis in the management of graft versus host disease: Narrative review. ImmunoTargets and Therapy, 235–246.
    [Cited by: 3]

  • Endalamaw, K., Tadesse, S., Asmare, Z., Kebede, D., Erkihun, M., & Abera, B. (2024). Antimicrobial resistance profile of bacteria from hospital wastewater at two specialized hospitals in Bahir Dar city, Ethiopia. BMC Microbiology, 24(1), 525.
    [Cited by: 3]

  • Erkihun, M., Chanie, D. N., & Siraj, Y. A. (2023). Antimicrobial‐Resistance Profile of Helicobacter pylori, Obtained from Endoscopic Patients in Bahir Dar, North West Ethiopia. Canadian Journal of Infectious Diseases and Medical Microbiology, 2023, Article ID 3615843.
    [Cited by: 3]

Dr.NABIL HASASNA | Hematomolecular pathologist | Future Science Leader Award

Dr.NABIL HASASNA | Hematomolecular pathologist | Future Science Leader Award

FELLOW at King Hussein Cancer Center, Jordan.

Dr. Nabil M. S. Hasasna is a dedicated and highly trained pathologist specializing in molecular and hemato-pathology. With over a decade of progressive experience across clinical pediatrics and diagnostic pathology, he is currently serving as a Fellow in Molecular Pathology at the esteemed King Hussein Cancer Center in Amman, Jordan. Known for his cross-disciplinary approach, Dr. Hasasna blends advanced diagnostic acumen with compassionate patient care, making him a valuable asset in the modern healthcare landscape.

Profile:

🎓 Educational Background:

Dr. Hasasna holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dow University of Health Sciences, Karachi, where he graduated with honors. He has earned prestigious certifications including the Diplomateship of the Royal College of Pathologists (UK) and the Arab Board in Anatomic Pathology. He also completed foundational stages in both the Arab and Palestinian Boards of Pediatrics, showcasing his diverse medical training.

Professional Experience:

Dr. Hasasna’s medical journey spans multiple disciplines. He served as a Pediatric Resident in various hospitals under the Palestine Ministry of Health, gaining hands-on experience in NICU, pediatric emergency, and hemato-oncology. Later, he advanced his expertise in pathology through a rigorous residency and fellowships at King Hussein Cancer Center, where he now contributes to cutting-edge diagnostic services in molecular and hemato-pathology.

Research Intrest:

Dr. Hasasna’s primary strengths lie in clinical diagnostics and laboratory medicine, he is currently focused on molecular-level cancer diagnostics, an area rapidly evolving with personalized medicine. His fellowships in Molecular-Pathology and Hemato-Pathology offer a platform for future research initiatives, particularly in genetic profiling and targeted therapies.

Honors and Recognitions:

Dr. Nabil M. S. Hasasna has earned notable recognition for his dedication to pathology and clinical excellence. He was awarded the Diplomateship of the Royal College of Pathologists (UK) in 2021, a prestigious certification that marks international distinction in diagnostic pathology. In the same year, he completed the Arab Board in Anatomic Pathology, a rigorous credential reflecting regional expertise in tissue-based diagnostics. His continuous academic advancement, including board qualifications in both surgical pathology and pediatrics, highlights his commitment to interdisciplinary excellence. Dr. Hasasna has contributed to impactful research, with publications cited internationally, and his work has gained visibility in respected journals such as the Journal of International Medical Research and Cancers. His professional affiliations with institutions like the King Hussein Cancer Center, known for high-level cancer diagnostics and research, further validate his reputation as a rising figure in molecular and hemato-pathology. These honors collectively reflect his growing influence in the medical and research community.

Publications:

🔹 APA Format:

Hasasna, N. M. S., [Other authors]. (2025). The role of [18F]FDG PET and clinicopathologic factors in detecting and predicting bone marrow involvement in non-Hodgkin lymphoma. Cancers.

🔹 MLA Format:

Hasasna, Nabil M. S., et al. “The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.” Cancers, 2025.

🔹 Chicago Style:

Hasasna, Nabil M. S., et al. 2025. “The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.” Cancers.

🔹 Vancouver Style:

Hasasna NMS, [Other authors]. The role of [18F]FDG PET and clinicopathologic factors in detecting and predicting bone marrow involvement in non-Hodgkin lymphoma. Cancers. 2025.

Ivan Hancco Zirena | Medicine and Dentistry | Lifetime achievement Award

Prof.Dr.Ivan Hancco Zirena | Medicine and Dentistry | Lifetime achievement Award

post doc at Harvard Medical School, Peru.

Dr. Ivan Hancco Zirena is a distinguished Peruvian physician and researcher specializing in clinical hematology, physiology, and high-altitude medicine. With a rich academic and clinical background spanning multiple continents, Dr. Hancco has carved a niche in understanding human adaptation to hypoxia and extreme environments. Currently serving as a postdoctoral researcher at the Thrombosis and Hemostasis Unit at Harvard Medical School’s Beth Israel Deaconess Medical Center, he contributes to groundbreaking studies on coagulation, red cell physiology, and novel antithrombotic agents.

Profile:

🎓 Educational Background:

Dr. Hancco earned his M.D. from the Universidad Nacional del Altiplano in Puno, Peru (2003), and later specialized in Hematology at Universidad Ricardo Palma, Lima. He pursued advanced studies in France, completing a Master’s in Integrated Biology and Physiology at Université Claude Bernard Lyon 1, followed by a Ph.D. in Physiology at Université Grenoble Alpes. His doctoral thesis investigated hematological responses in high-altitude populations living above 5,000 meters, under the supervision of Dr. Samuel Verges. He is currently completing a postdoctoral fellowship at Harvard Medical School (2023–2025).

💼 Professional Experience:

Dr. Hancco brings extensive experience in both clinical and academic medicine. He has worked in emergency care, hematology units, and cardiovascular rehabilitation in Peru, France, and Spain. His research roles at Laboratoire HP2 (France) and currently at Harvard Medical School (USA) have sharpened his focus on high-impact clinical studies. Additionally, he has provided care to patients with benign and malignant hematologic diseases in military and public hospitals.

Research Interests:

Dr. Hancco’s primary research explores the physiological and hematological adaptations to hypoxia, chronic mountain sickness, erythrocytosis, and cardiovascular and thrombotic responses at high altitudes. His recent work delves into the role of thiol isomerases in hemostasis and thrombosis, with applications in vascular medicine and novel antithrombotic therapies. His interdisciplinary approach bridges physiology, hematology, environmental medicine, and cellular biology.

Teaching Experience:

A passionate educator, Dr. Hancco has taught hematology, physiology, and molecular biology at top Peruvian universities including Universidad de San Martín de Porres, Universidad Científica del Sur, and Universidad Nacional del Altiplano. He has led student research groups, facilitated international exchange programs, and integrated research into medical training. His teaching style fosters critical thinking, debate, and hands-on learning in laboratory and clinical environments.

Skills:

Dr. Hancco is skilled in a wide array of biomedical techniques including flow cytometry, cell culture, platelet aggregation, protein purification, magnetic cell levitation, cytokinesis analysis, microscopy, and complete blood count analysis. These tools have supported his innovative research in hypoxia and hemostasis.

🏅 Recognition and Impact:

Dr. Hancco’s research on chronic mountain sickness and thrombosis has global relevance, particularly for populations living in extreme altitudes. His findings contribute to improved diagnostic and therapeutic strategies for hematological disorders in both high- and low-altitude settings. His work has earned him collaboration with world-renowned institutions and recognition as a rising figure in global hematology and physiology.

Publications:

  • Galloylated polyphenols represent a new class of antithrombotic agents with broad activity against thiol isomerases.
    Journal of Thrombosis and Haemostasis, 2025.

  • Cerebral blood flow in Andean children and adolescents living above 5,000 m.
    Journal of Neurophysiology, 2025.

  • Neurological manifestations associated with exercise at altitude.
    Current Neurology and Neuroscience Reports, 2025.

  • Pain perception threshold in young high-altitude natives after acute exposure to severe hypoxic conditions.
    Oxygen (Basel), 2025.

  • Micro- and macrovascular function in the highest city in the world: A cross-sectional study.
    Lancet Regional Health – Americas, 2024.

  • Performance in the six-minute walking test does not discriminate excessive erythrocytosis patients in a severe hypoxic environment.
    International Journal of Environmental Research and Public Health, 2024.

  • Expedition 5300: Limits of human adaptations in the highest city in the world.
    Journal of Physiology, 2024.

  • Cerebral homeostasis and orthostatic responses in residents of the highest city in the world.
    Scientific Reports, 2024.

  • Lower glycemia levels in subjects with excessive erythrocytosis during the oral glucose tolerance test living in conditions of severe hypoxia.
    Frontiers in Physiology, 2024.

  • Are coagulation profiles in Andean highlanders with excessive erythrocytosis favouring hypercoagulability?
    Experimental Physiology, 2024.

Anna Kakehashi | Medicine and Dentistry | Best Researcher Award

Assoc.Prof.Dr.Anna Kakehashi | Medicine and Dentistry | Best Researcher Award 

Ph.D., D.M.Sc. at Osaka Metropolitan University Graduate School of Medicine, Japan.

Dr. Anna Kakehashi is a distinguished molecular pathologist and cancer researcher with over two decades of experience in the field of experimental pathology, chemical carcinogenesis, and biomarker discovery. As an Associate Professor at the Graduate School of Medicine, Osaka Metropolitan University, Japan, she has built a formidable career focusing on the mechanisms of liver and pancreatic carcinogenesis, with an emphasis on oxidative stress, DNA damage, and molecular diagnostics. Dr. Kakehashi is widely respected for her scientific rigor, international collaborations, and contributions to cancer prevention and public health research.

Profile:

🎓 Educational Background:

Dr. Kakehashi began her academic journey at St. Petersburg State University, Russia, where she earned her Master of Science in Biology (Biochemistry) in 1995. She later pursued doctoral research at Osaka City University, Japan, obtaining her Ph.D. in Medical Science in 2003. Her multidisciplinary education in biochemistry and medical science laid a strong foundation for her path-breaking research in toxicologic and molecular pathology.

💼 Professional Experience:

Starting her postdoctoral career in 2003, Dr. Kakehashi progressed from a research fellow to an assistant professor, and eventually to her current position as Associate Professor. She has held various key roles at Osaka City University (now Osaka Metropolitan University), contributing to research in pathology and mentoring graduate students. Her academic service includes editorial roles for journals like Cancers (MDPI) and Journal of Medical Laboratory Science.

🧪 Research Interests:

Dr. Kakehashi’s research revolves around the molecular mechanisms of chemical and viral carcinogenesis, particularly in liver (MAFLD/MASH and HCC) and pancreatic cancer. Her expertise includes the identification of novel biomarkers, risk assessment of chemical agents, proteomic and metabolomic profiling, and studying the role of oxidative stress and DNA repair in cancer progression. She is especially noted for her work on the hormesis phenomenon and the evaluation of environmental carcinogens.

🏅 Awards and Honors:

Dr. Kakehashi has been recognized with numerous prestigious awards. These include the Princess Takamatsu Cancer Research Fund Award (2022), the Osaka City Medical Association Award (2018), and the Dean’s Award for Excellence from Osaka City University School of Medicine. Her early-career brilliance was acknowledged through the Japanese Society of Toxicology Young Researcher Award and Toxicological Pathology Presentation Award. These accolades affirm her scientific contributions and leadership in cancer research.

🤝 Collaborations and Affiliations:

Dr. Kakehashi is a proactive collaborator, having worked with institutions in Thailand, Russia, and the USA, including St. Petersburg State University and LyondellBasell Industries. In Japan, she has collaborated with numerous university departments and research institutes on carcinogenesis, biomarker discovery, and nanomaterial safety. She is also a longstanding member and councillor of multiple scientific societies such as the Japanese Cancer Association, Society of Toxicologic Pathology, and Japanese Society for Cancer Prevention.

🌍 Community Engagement:

Beyond the lab, Dr. Kakehashi is deeply committed to gender equity in research. She has actively participated in initiatives by Japan’s Ministry of Education to improve research environments for women and promote work-life balance. Her involvement in national review committees also reflects her leadership in shaping research directions at the policy level.

Publications:

  • “Metabolism and effects of acetoaceto-o-toluidine in the urinary bladder of humanized-liver mice”
    Journal of Toxicologic Pathology, 2025

  • “Nicotine promotes the development of invasive bladder carcinoma in rats”
    Journal of Toxicologic Pathology, 2025

  • “Comparative analysis of the toxic effects on the mouse lung of 4 weeks exposure to the heated tobacco product Ploom TECH+ and 3R4F reference cigarettes”
    Journal of Toxicologic Pathology, 2025

  • “Urinary bladder carcinogenic potential of 4,4′-methylenebis(2-chloroaniline) in humanized-liver mice”
    Toxicological Sciences, 2024

  • “Fullerene and fullerene whisker are not carcinogenic to the lungs and pleura in rat long-term study after 2-week intra-tracheal intrapulmonary administration”
    Archives of Toxicology, 2024

  • “Characterizing the toxicological responses to inorganic arsenicals and their metabolites in immortalized human bladder epithelial cells”
    Archives of Toxicology, 2024

  • “Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma”
    Frontiers in Oncology, 2024

  • “Evaluation of the mechanisms involved in the development of bladder toxicity following exposure to occupational bladder cancer causative chemicals using DNA adductome analysis”
    Biomolecules, 2024

  • “DNA Methylation Aberrations in Dimethylarsinic Acid-Induced Bladder Carcinogenesis”
    Cancers, 2023

  • “Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis”
    Cancers, 2023 (Review Article)

Zhuo Sun | Genetics and Molecular Biology | Best Researcher Award

Dr.Zhuo Sun | Genetics and Molecular Biology | Best Researcher Award

Lecturer at Chengdu Normal University, China.

Dr. Zhuo Sun is a researcher and lecturer at Chengdu Normal University, China, specializing in sports genetics, molecular metabolomics, and injury prevention. He earned his Ph.D. in Genetics and ACL Injury from the Gdansk University of Physical Education and Sport, Poland. His research focuses on the genetic determinants of soft tissue injuries and metabolic responses to physical exercise, with over 14 peer-reviewed publications in international journals. Dr. Sun has participated in national and international research projects, presented at global conferences, and received multiple academic fellowships. His work bridges the gap between molecular biology and sports performance, aiming to improve athlete health and recovery through precision science.

Profile:

🎓 Education Background:

Dr. Zhuo Sun holds a Ph.D. in Genetics & ACL Injury from the Gdansk University of Physical Education and Sport in Poland (2021–2024), where he conducted pioneering research on the genetic risks associated with non-contact anterior cruciate ligament injuries. He also earned a Master’s degree in Sports Physiology & Anatomy from Shanxi University, China (2016–2019), and a Bachelor’s degree in Kinesiology from the University of Dalian, China (2012–2016). His academic foundation seamlessly blends biological science with athletic performance, providing him with a multidisciplinary edge.

💼 Professional Experience:

Dr. Zhuo Sun is currently serving as a Lecturer in the Department of Physical Education at Chengdu Normal University, China, since January 2025, where he contributes to both academic instruction and research in sports science and injury prevention. Prior to this, he held a teaching and research position at the Department of Sports Medicine and Rehabilitation at North Sichuan College in 2024, focusing on musculoskeletal health, rehabilitation techniques, and exercise physiology. During his Ph.D. studies (2021–2024) at Gdansk University of Physical Education and Sport in Poland, Dr. Sun worked as a Research Assistant and Teaching Assistant, actively participating in genetic and proteomic investigations related to ACL injuries, while also supporting classroom instruction and international research projects. In 2019, he gained international exposure as a Visiting Scholar at the Division of Kinesiology and Nutritional Science, California State University, Los Angeles, enhancing his global perspective and collaborative research experience. His professional journey reflects a strong foundation in academic teaching, molecular research, and international cooperation in sports and health sciences.

🧬 Research Interests:

Dr. Sun’s research is focused on genetics, molecular metabolomics, proteomics, and the regulation of functional proteins in sports medicine. He is particularly interested in identifying gene variants that contribute to musculoskeletal injuries among athletes, aiming to bridge molecular science with practical applications in injury prevention and rehabilitation. His work on biomarkers and metabolic profiling also sheds light on exercise recovery and performance enhancement.

🏅 Awards & Honors:

Dr. Sun has received multiple honors recognizing his academic excellence and research potential. He was awarded a 1st-class Academic Fellowship in 2017, 2018, and 2019 by Shanxi University. He also secured a National Soft Tissue Injury Mechanism Research Grant (2024–2027), and was a visiting scholar at California State University, LA in 2019. In 2023, he served as a translator and assistant researcher during an International Research Summer Camp in Poland, showcasing his multilingual and cross-cultural abilities.

🌍 Conferences & International Exposure:

Dr. Sun has presented his research at several notable conferences, including the 3rd International Congress of the Polish Society of Muscles, Tendons, and Bonds in 2022, and international seminars in China focusing on sports health and metabolomics. His ability to collaborate across borders and cultures demonstrates his global perspective and dedication to academic exchange.

🧠 Core Skills:

Dr. Sun is skilled in molecular biology techniques, sports genomics, non-targeted metabolomics (UHPLC-MS, ¹H-NMR), systematic reviews and meta-analysis, and scientific writing. His interdisciplinary approach combines laboratory expertise with real-world sports health applications, making his skill set highly relevant to modern sports science, injury prevention, and precision medicine.

Publication:

  • The COL27A1 and COL11A1 gene variants are not associated with the susceptibility to anterior cruciate ligament rupture in Polish athletes
    Baltic Journal of Health and Physical Activity, 2023

  • Genetic Determinants of the Anterior Cruciate Ligament Rupture in Sport: An Up-to-Date Systematic Review
    Journal of Human Kinetics, 2023

  • Mechanism of the Effect of High-Intensity Training on Urinary Metabolism in Female Water Polo Players Based on UHPLC-MS Non-Targeted Metabolomics Technique
    Healthcare (Basel, Switzerland), 2021

  • 1H NMR-based metabolomics approach for exploring the effect of astaxanthin supplementation on plasma metabolites after high-intensity physical exercise
    Journal of Men’s Health, 2021

  • Effect of astaxanthin and exercise on antioxidant capacity of human body, blood lactic acid and blood uric acid metabolism
    Science & Sports, 2019

  • Effect of Astaxanthin Supplementation on Antioxidant Capacity, Blood Lactate and Blood Uric Acid Metabolism in Human Recovery Stage After Exercise
    Advances in Bioscience and Bioengineering, 2019